Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
925
-
Total 13F shares, excl. options
-
363M
-
Shares change
-
+6.09M
-
Total reported value, excl. options
-
$31.7B
-
Value change
-
+$614M
-
Put/Call ratio
-
1.01
-
Number of buys
-
445
-
Number of sells
-
-444
-
Price
-
$87.29
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q2 2025
1,096 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q2 2025.
DEXCOM INC - Common Stock (DXCM) has 925 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 363M shares
of 392M outstanding shares and own 92.74% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (48.3M shares), BlackRock, Inc. (39M shares), STATE STREET CORP (16.9M shares), BAILLIE GIFFORD & CO (16.7M shares), JENNISON ASSOCIATES LLC (11.5M shares), GEODE CAPITAL MANAGEMENT, LLC (10.8M shares), SANDS CAPITAL MANAGEMENT, LLC (9.95M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (9.13M shares), Nuveen, LLC (7.57M shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (6.61M shares).
This table shows the top 925 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.